TTrialPathMatch Me to Trials
← Back to trials
RecruitingGastroschisis

Gastroschisis Outcomes of Delivery (GOOD) Study

Eligible age

18+ yrs

Accepts

Women

Locations

25 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The objective of this study is to investigate the hypothesis that delivery at 35 0/7- 35 6/7 weeks in stable patients with gastroschisis is superior to observation and expectant management with a goal of delivery at 38 0/7 - 38 6/7 weeks. To test this hypothesis, we will complete a randomized, prospective, multi-institutional trial across NAFTNet-affiliated institutions. Patients may be enrolled in the study any time prior to 33 weeks, but will be randomized at 33 weeks to delivery at 35 weeks or observation with a goal of 38 weeks. The primary composite outcome will include stillbirth, neonatal death prior to discharge, respiratory morbidity, and need for parenteral nutrition at 30 days.

Sponsor: Medical College of Wisconsin

You may qualify if…

  • To be eligible for study inclusion, subjects are required to meet the following criteria:
  • 1. Speak English or Spanish
  • 2. Age of ≥18 years old
  • 3. Have a diagnosis of an isolated fetal gastroschisis confirmed via sonogram at ≤33 weeks gestation
  • 4. Have a singleton pregnancy
  • 5. Capable of providing written informed consent for study participation
  • 6. Established Estimated Date of Confinement (EDC) prior to 22 0/7 weeks GA by last menstrual period (LMP) with ultrasound confirmation or ultrasound dating when LMP is unknown.

You may not qualify if…

  • Subjects will be excluded from enrollment for any of the following criteria
  • 1. Fetal anomaly unrelated to gastroschisis, such as a chromosomal abnormality or another congenital structural abnormality (if known; no additional testing required for research participation)
  • 2. Severe intrauterine growth restriction / fetal growth restriction (defined as growth below the 5th percentile for gestational age)
  • 3. Maternal history of previous stillbirth (intrauterine fetal demise)
  • 4. Maternal history of spontaneous preterm (\<36 weeks) delivery
  • 5. Maternal cervical length \< 25 mm prior to 24 weeks of gestation if documented
  • 6. Maternal hypertension
  • 7. Maternal insulin-dependent diabetes

Where it's recruiting

Arizona

Phoenix

California

Loma Linda · Stanford

Colorado

Aurora

Connecticut

Hartford

Delaware

Wilmington

Florida

Tampa

Georgia

Atlanta

Illinois

Chicago · Peoria

Indiana

Indianapolis

Kentucky

Lousiville

Maryland

Baltimore

Source: ClinicalTrials.gov · NCT02774746 · last updated 2026-05-27